BIO Bio-Rad Laboratories, Inc.: Net earnings per share for the last four quarters
Despite geopolitical barriers in medtech exports, Bio-Rad Laboratories relies on a steady cash flow from the sale of consumables. The year-over-year EPS (TTM) history demonstrates profit dynamics, where the current mark is 258.20. A comprehensive ecosystem of laboratory solutions provides fundamental strength, retaining customers through deep equipment integration.
%3A%20Bio-Rad%20Corp%20%5Blogo%5D%20BIO&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_BIO_-_Bio-Rad-Laboratories_-_Net-earnings-per-share-EPS-TTM "BIO (Bio-Rad Corp) Earnings per share for the last twelve months history from 02/11/2024 to 11/13/2026 | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for Bio-Rad Laboratories Inc (BIO)
- market price and analyst price targets:
- company stock capitalization data:
- book value of equity indicators:
- company total debt and liquidity indicators:
- earnings and valuation multiples indicators:
BIO - Net Income|Expected Net Income Bio-Rad Laboratories|BIO - Price to Earnings Ratio|Future Price to Earnings Bio-Rad Laboratories, Inc.|BIO - PEG Multiple|EV/EBITDA Multiple Bio-Rad Laboratories Inc|BIO - Operating profit EBITDA|Earnings per share for the last twelve months Bio-Rad|BIO - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months bio-rad.com|BIO - Earnings per share growth in current year|Expected earnings per share trend next year Bio-Rad Laboratories
- sales and revenue indicators:
Initial company analysis:bio-rad.com BIO
This indicator measures the net profit per share dynamics over the last twelve months, allowing for an assessment of the scaling pace of the business's actual earnings. By analyzing the relative change in EPS YoY (TTM), an investor determines the implementation efficiency of Bio-Rad Laboratories (BIO) clinical diagnostic systems and laboratory equipment, where sustainable profit growth confirms market demand for high-tech reagents.
Competitor analysis for Bio-Rad Laboratories
Net earnings per share for the last four quarters agilent.com A|Quest Diagnostics Incorporated (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|EXAS (Cologuard) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months RVTY|Net earnings per share (EPS TTM) NNNN|Net earnings per share for the last four quarters soterahealth.com|Earnings per share for the last twelve months QuidelOrtho Corporation QDEL|OPKO Health Inc (OPK) - Net earnings per one share for the last twelve months|CDNA: Net earnings per share for the last 12 months|Net earnings per share for the trailing year Maravai (MRVI)|Fulgent Genetics, Inc. (FLGT) - Earnings per share for the last twelve months|fluidigm.com - Earnings per share for the trailing year|CTKB (Cytek Biosciences) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) OraSure Technologies, Inc.|Net earnings per share (EPS TTM) XGN|MDxHealth, Inc. - Earnings per share for the last 12 months|Lucid Diagnostics Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRE|IMDX - Earnings per share for the last twelve months|TRIB: Earnings per share for the last twelve months|PRPH: Net earnings per share (EPS TTM)|Ainos Corporation (AIMD) - Net earnings per share (EPS TTM)|CODX (Co-Diagnostics, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months HSCS|Earnings per share for the last twelve months Biomerica (BMRA)|CDIO - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Onconetix Corp ONCO|Earnings per share for the trailing year VRAX|Bluejay Diagnostics - Net earnings per share (EPS TTM)|AWH - Net earnings per share (EPS TTM)|AXDX (Accelerate Diagnostics, Inc.) - Net earnings per share for the last 12 months|CNTG: Earnings per share for the last four quarters|Earnings per share for the last twelve months Enzo Biochem Inc.|Net earnings per one share for the last twelve months Fresh2 FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|ME (23andme.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PMD (Psychemedics Corporation)
